| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |